MARKET

ABBV

ABBV

Abbvie Inc
NYSE
266.28
+1.94
+0.73%
After Hours: 267.79 +1.51 +0.57% 19:59 09/28 EDT
OPEN
264.33
PREV CLOSE
264.34
HIGH
267.74
LOW
263.38
VOLUME
4.43M
TURNOVER
--
52 WEEK HIGH
269.39
52 WEEK LOW
189.65
MARKET CAP
470.55B
P/E (TTM)
75.31
1D
5D
1M
3M
1Y
5Y
1D
Should FDA Approval Require Action From AbbVie (ABBV) Investors?
Simply Wall St · 8h ago
Top Research Reports for Alphabet, Mastercard & AbbVie
NASDAQ · 10h ago
AbbVie’s New Parkinson’s Pill Could Become a Billion-Dollar Drug, Analyst Says
Benzinga · 12h ago
Analysts Are Bullish on Top Healthcare Stocks: Medicinova (MNOV), AbbVie (ABBV)
TipRanks · 15h ago
8 Of 11 Sectors Fall In Monday Trading As Defensives Lead
Benzinga · 15h ago
AbbVie Gets FDA OK of Juvmo for Parkinson's Disease
Dow Jones · 17h ago
AbbVie’s JUVMO wins FDA approval for Parkinson’s disease
Seeking Alpha · 17h ago
AbbVie announces FDA approval of Juvmo to treat Parkinson’s disease
TipRanks · 18h ago
More
About ABBV
AbbVie Inc. is a global, diversified, research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. The aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Duodopa is a levodopa-carbidopa intestinal gel for the treatment of Parkinson's disease. Eye care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, and Restasis. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its pipeline also includes zumilokibart and APG273.

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.